Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
Circulating IL-8 and osteopontin appear useful biomarkers to refine prognosis evaluation of patients undergoing targeted therapy, and deserve attention as potential targets to improve its clinical efficacy.
Authors
- Pedro Miguel Lacal (ORCID: https://orcid.org/0000-0003-1166-4593)
- Francesco Facchiano (ORCID: https://orcid.org/0000-0003-4313-0617)
- Ester Alvino (ORCID: https://orcid.org/0000-0001-9467-7634)
- Gian Carlo Antonini Cappellini (ORCID: https://orcid.org/0000-0001-7978-6947)
- Federica De Galitiis
- Antonio Facchiano (ORCID: https://orcid.org/0000-0002-4243-2392)
- Giandomenico Russo (ORCID: https://orcid.org/0000-0002-7718-9687)
- Stefania D’Atri (ORCID: https://orcid.org/0000-0001-9852-7377)
- Simona Caporali
- Laura Bonmassar
- Enrico Scala (ORCID: https://orcid.org/0000-0002-9391-9168)
- Claudio Tabolacci (ORCID: https://orcid.org/0000-0001-5001-285X)
- Antonella Bresin (ORCID: https://orcid.org/0000-0003-3954-5481)
- Lauretta Levati
Institutions
- Istituto Superiore di Sanità (IT)
- Istituto Dermopatico dell'Immacolata (IT)
- Associazione Italiana Di Oncologia Medica (IT)
- IRCCS San Camillo Hospital (IT)
- Istituto di Farmacologia Traslazionale (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Journal of Experimental & Clinical Cancer Research
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1186/s13046-024-03151-3
- Citations
- 5
- Primary Topic
- Bone and Dental Protein Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.35
Funders
- Ministero della Salute
- Banca d'Italia
- Istituto Superiore di Sanità
- Fondazione Umberto Veronesi